KMID : 1143220200630020150
|
|
Obstetrics & Gynecology Science 2020 Volume.63 No. 2 p.150 ~ p.157
|
|
Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study
|
|
Carbajal-Mamani Semiramis L.
Schweer David Markham Merry J. Esnakula Ashwini K. Grajo Joseph R. Castagno Jacqueline C. Cardenas-Goicoechea Joel
|
|
Abstract
|
|
|
Objective: The primary objective was to assess the feasibility of robotic-assisted interval cytoreductive surgery for achieving complete cytoreduction for patients with advanced-stage ovarian cancer. The secondary objective was to examine the perioperative outcomes.
Methods: A retrospective study of 12 patients with stage IIIC or IV ovarian, fallopian tube, and primary peritoneal carcinoma who underwent interval cytoreductive surgery after neo-adjuvant chemotherapy.
Results: Optimal cytoreduction was achieved in 100% of selected patients. Complete cytoreductive surgery was achieved in 75% of patients. The estimated mean blood loss was 100 mL. The median length of hospital stay was 2 days. Perioperative complication and 30-day readmission rates were 8.3% (1 patient). The median follow-up time was 9.5 months.
Conclusion: Robotic-assisted interval cytoreductive surgery in ovarian cancer is safe and feasible and may be an alternative to standard laparotomy in selected patients.
|
|
KEYWORD
|
|
Robotic surgical procedure, Ovarian cancer, Cytoreductive surgical procedure
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|